Truncation and sequence shuffling of segment 6 generate replication-competent neuraminidase-negative influenza H5N1 viruses

Journal of Virology

Volumn 87, Issue 24, 2013, Pages 13556-13568

  Kalthoff, Donata ^a   Röhrs, Susanne ^a   Höper, Dirk ^a   Hoffmann, Bernd ^a   Bogs, Jessica ^a   Stech, Jürgen ^a   Beer, Martin ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS SIALIDASE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHICKEN; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC RECOMBINATION; INFLUENZA VIRUS A H5N1; NONHUMAN; PRIORITY JOURNAL; REVERSE GENETICS; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANIMALS; CHICKENS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; MUTAGENESIS, INSERTIONAL; NEURAMINIDASE; POULTRY DISEASES; SEQUENCE DELETION; SERIAL PASSAGE; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84888068986     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02244-13     Document Type: Article

References (51)

1. Peiris JSM, de Jong MD, Guan Y. 2007. Avian influenza virus (H5N1):a threat to human health. Clin. Microbiol. Rev. 20:243-267.
2. Swayne DE. 2009. Avian influenza vaccines and therapies for poultry. Comp. Immunol. Microbiol. Infect. Dis. 32:351-363.
3. Earn DJD, Dushoff J, Levin SA. 2002. Ecology and evolution of the flu. Trends Ecol. Evol. 17:334-340.
4. Kilany WH, Arafa A, Erfan AM, Ahmed MS, Nawar AA, Selim AA, Khoulosy SG, Hassan MK, Aly MM, Hafez HM, Abdelwhab EM. 2010. Isolation of highly pathogenic avian influenza H5N1 from table eggs after vaccinal break in commercial layer flock. Avian Dis. 54:1115-1119.
5. Abdelwhab el-SM, Erfan AM, Grund C, Ziller M, Arafa AS, Beer M, Aly MM, Hafez HM, Harder TC. 2010. Simultaneous detection and differentiation by multiplex real-time RT-PCR of highly pathogenic avian influenza subtype H5N1 classic (clade 2.2.1 proper) and escape mutant (clade 2.2.1 variant) lineages in Egypt. Virol. J. 7:260.
6. Grund C, Abdelwhab el-SM, Arafa AS, Ziller M, Hassan MK, Aly MM, Hafez HM, Harder TC, Beer M. 2011. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine 29:5567-5573.
7. Ferreira HL, Lambrecht B, van Borm S, Torrieri-Dramard L, Klatzmann D, Bellier B, van den Berg T. 2010. Identification of a dominant epitope in the hemagglutinin of an Asian highly pathogenic avian influenza H5N1 clade 1 virus by selection of escape mutants. Avian Dis. 54:565-571.
8. Rudneva IA, Kushch AA, Masalova OV, Timofeeva TA, Klimova RR, Shilov AA, Ignatieva AV, Krylov PS, Kaverin NV. 2010. Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus. Viral Immunol. 23:181-187.
9. Kryazhimskiy S, Dushoff J, Bazykin GA, Plotkin JB. 2011. Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet. 7:e1001301. doi:10.1371/journal.pgen.1001301.
10. Höper D, Kalthoff D, Hoffmann B, Beer M. 2012. Highly pathogenic avian influenza virus subtype H5N1 escaping neutralization:more than HA variation. J. Virol. 86:1394-1404.
11. Weber S, Harder T, Starick E, Beer M, Werner O, Hoffmann B, Mettenleiter TC, Mundt E. 2007. Molecular analysis of highly pathogenic avian influenza virus of subtype H5N1 isolated from wild birds and mammals in northern Germany. J. Gen. Virol. 88:554-558.
12. Rudolf M, Pöppel M, Fröhlich A, Breithaupt A, Teifke J, Blohm U, Mettenleiter T, Beer M, Harder T. 2010. Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens. Vaccine 28:6832-6840.
13. Höper D, Hoffmann B, Beer M. 2009. Simple, sensitive, and swift sequencing of complete H5N1 avian influenza virus genomes. J. Clin. Microbiol. 47:674-679.
14. Leifer I, Hoffmann B, Höper D, Bruun Rasmussen T, Blome S, Strebelow G, Höreth-Böntgen D, Staubach C, Beer M. 2010. Molecular epidemiology of current classical swine fever virus isolates of wild boar in Germany. J. Gen. Virol. 91:2687-2697.
15. Sanger F, Nicklen S, Coulson AR. 1977. DNA sequencing with chainterminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74:5463-5467.
16. Darling ACE, Mau B, Blattner FR, Perna NT. 2004. Mauve:multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 14:1394-1403.
17. R Development Core Team. 2009. R:a language and environment for statistical computing, version 2.10.1. R Foundation for Statistical Computing, Vienna, Austria
18. Stech J, Stech O, Herwig A, Altmeppen H, Hundt J, Gohrbandt S, Kreibich A, Weber S, Klenk HD, Mettenleiter TC. 2008. Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification. Nucleic Acids Res. 36:e139. doi:10.1093/nar/gkn646.
19. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U.S.A. 97:6108-6113.
20. Bahnemann HG. 1990. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. Vaccine 8:299-303.
21. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM. 1999. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:937-943.
22. International Office of Epizootics. 2008. Manual of diagnostic tests and vaccines for terrestrial animals, 6th ed. International Office of Epizootics, Paris, France.
23. Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W. 2009. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Vaccine 27:773-785.
24. Hoffmann B, Harder T, Starick E, Depner K, Werner O, Beer M. 2007. Rapid and highly sensitive pathotyping of avian influenza AH5N1 virus by using real-time reverse transcription-PCR. J. Clin. Microbiol. 45:600-603.
25. Hoffmann B, Depner K, Schirrmeier H, Beer M. 2006. A universal heterologous internal control system for duplex real-time RT-PCR assays used in a detection system for pestiviruses. J. Virol. Methods 136:200-209.
26. Hoffmann B, Harder T, Lange E, Kalthoff D, Reimann I, Grund C, Oehme R, Vahlenkamp TW, Beer M. 2010. New real-time reverse transcriptase polymerase chain reactions facilitate detection and differentiation of novel A/H1N1 influenza virus in porcine and human samples. Berl. Munch. Tierarztl. Wochenschr. 123:286-292.
27. Gohrbandt S, Veits J, Hundt J, Bogs J, Breithaupt A, Teifke JP, Weber S, Mettenleiter TC, Stech J. 2011. Amino acids adjacent to the haemagglutinin cleavage site are relevant for virulence of avian influenza viruses of subtype H5. J. Gen. Virol. 92:51-59.
28. Rudolf M, Pöppel M, Fröhlich A, Mettenleiter T, Beer M, Harder T. 2009. Efficacy of a commercial inactivated H5 influenza vaccine against highly pathogenic avian influenza H5N1 in waterfowl evaluated under field conditions. Rev. Sci. Tech. 28:275-291.
29. Archetti I, Horsfall JFL. 1950. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. J. Exp. Med. 92:441-462.
30. Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Krylov PS, Webster RG. 2007. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J. Virol. 81:12911-12917.
31. Philpott M, Hioe C, Sheerar M, Hinshaw VS. 1990. Hemagglutinin mutations related to attenuation and altered cell tropism of a virulent avian influenza A virus. J. Virol. 64:2941-2947.
32. Lambkin R, McLain L, Jones SE, Aldridge SL, Dimmock NJ. 1994. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus:a possible mechanism for antigenic drift. J. Gen. Virol. 75:3493-3502.
33. Cleveland SM, Taylor HP, Dimmock NJ. 1997. Selection of neutralizing antibody escape mutants with type A influenza virus HA-specific polyclonal antisera:possible significance for antigenic drift. Epidemiol. Infect. 118:149-154.
34. Laver WG, Air GM, Webster RG, Markoff LJ. 1982. Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase. Virology 122:450-460.
35. Spackman E. 2008. A brief introduction to the avian influenza virus. Methods Mol. Biol. 436:1-6.
36. Mori K, Haruyama T, Nagata K. 2011. Tamiflu-resistant but HAmediated cell-to-cell transmission through apical membranes of cellassociated influenza viruses. PLoS One 6:e28178. doi:10.1371/journal.pone.0028178.
37. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y. 2000. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J. Virol. 74:6015-6020.
38. Liu C, Air GM. 1993. Selection and characterization of a neuraminidaseminus mutant of influenza virus and its rescue by cloned neuraminidase genes. Virology 194:403-407.
39. Yang P, Bansal A, Liu C, Air GM. 1997. Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses. Virology 229:155-165.
40. LeBouder F, Lina B, Rimmelzwaan GF, Riteau B. 2010. Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase. J. Gen. Virol. 91:2753-2761.
41. Gulati S, Smith DF, Air GM. 2009. Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses. Virol. J. 6:22.
42. Moules V, Ferraris O, Terrier O, Giudice E, Yver M, Rolland JP, Bouscambert-Duchamp M, Bergeron C, Ottmann M, Fournier E, Traversier A, Boule C, Rivoire A, Lin Y, Hay A, Valette M, Marquet R, Rosa-Calatrava M, Naffakh N, Schoehn G, Thomas D, Lina B. 2010. In vitro characterization of naturally occurring influenza H3NA-viruses lacking theNAgene segment:toward a new mechanism of viral resistance? Virology 404:215-224.
43. Hughes MT, Matrosovich M, Rodgers ME, McGregor M, Kawaoka Y. 2000. Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice. J. Virol. 74:5206-5212.
44. Gubareva LV, Nedyalkova MS, Novikov DV, Murti KG, Hoffmann E, Hayden FG. 2002. A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site. J. Gen. Virol. 83:2683-2692.
45. Von Magnus P. 1951. Propagation of the PR8 strain of influenza A virus in chick embryos. III. Properties of the incomplete virus produced in serial passages of undiluted virus. Acta Pathol. Microbiol. Scand. 29:157-181.
46. Fujii Y, Goto H, Watanabe T, Yoshida T, Kawaoka Y. 2003. Selective incorporation of influenza virus RNA segments into virions. Proc. Natl. Acad. Sci. U.S.A. 100:2002-2007.
47. Ada GL, Lind PE. 1961. Neuraminidase in the chorioallantois of the chick embryo. Nature 190:1169-1171.
48. Tisoncik JR, Guo Y, Cordero KS, Yu J, Wang J, Cao Y, Rong L. 2011. Identification of critical residues of influenza neuraminidase in viral particle release. Virol. J. 8:14.
49. Su B, Wurtzer S, Rameix-Welti MA, Dwyer D, van der Werf S, Naffakh N, Clavel F, Labrosse B. 2009. Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA). PLoS One 4:e8495. doi:10.1371/journal.pone.0008495.
50. Markoff LJ, Murphy BR, Kendal AJ, Chanock RM. 1979. Probable association of plaque size with neuraminidase subtype among H3N2 influenza A viruses. Brief report. Arch. Virol. 62:277-280.
51. Schauer R. 2004. Victor Ginsburg's influence on my research of the role of sialic acids in biological recognition. Arch. Biochem. Biophys. 426:132-141.